Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rybelsus (Semaglutide) in Adults With Alcohol Use Disorder
NCT05892432Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Jan 2024
- Primary completion
- Nov 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in alcohol use disorder (AUD), sponsored by University of Colorado Denver. Started Jan 2024; status: completed.
02
Drugs
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05892432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05892432.